
Drug testing of newborns is a controversial topic that varies across US states. While there are no standardized drug testing requirements for newborns, some states have legislation in place to protect infants. In Utah, research has been conducted on drug exposure in newborns, including the testing of umbilical cord tissue and meconium to understand the presence of drugs and their potential impact on newborn health. The University of Utah Health has also published information on babies exposed to drugs before birth, highlighting the signs and symptoms of drug exposure, such as irritability, shrieks, and seizures. While the specific drug testing policies for newborns in Utah hospitals are not explicitly mentioned, the state's involvement in research and awareness about drug exposure in newborns suggests a proactive approach to addressing this issue.
| Characteristics | Values |
|---|---|
| Federal law on drug testing newborns | There is no federal law mandating hospitals to test pregnant women or newborns |
| State law on drug testing newborns in Utah | No explicit mention of Utah state law on drug testing newborns |
| Drug testing methods | Urine, meconium, blood, hair, umbilical cord blood or tissue samples |
| Drug testing approaches | Universal or risk-based |
| Risk-based testing criteria | Maternal history of substance use, social risk factors, limited or absent prenatal care, symptoms of withdrawal |
| Testing for neonatal drug exposure | Same methods as adult drug testing (e.g., MS, immunoassay) |
Explore related products
What You'll Learn
- Hospitals in Utah test newborns for drugs using umbilical cord tissue and meconium
- Mothers are advised to be truthful about their drug use to receive better care during pregnancy
- Drug withdrawal symptoms in newborns include irritability, shrieks, seizures, and increased heart rate
- Hospitals take a risk-based approach to testing infants, considering maternal history and social risk factors
- In some states, women can be charged with child abuse or criminally indicted for drug use during pregnancy

Hospitals in Utah test newborns for drugs using umbilical cord tissue and meconium
There are no standardized drug testing requirements that mandate hospitals to test pregnant women or their newborns. However, hospitals in Utah do test newborns for drugs, using umbilical cord tissue and meconium. Meconium is the first stool of a newborn, composed of materials ingested while the infant is still in the uterus. Umbilical cord tissue testing is relatively new but is preferred, along with meconium testing, for evaluating chronic exposure.
The decision to test a newborn for drugs is typically based on risk factors such as a maternal history of substance use disorder or signs of drug use. Hospitals generally take a risk-based approach to testing infants, and medical staff will only drug test babies of mothers who are suspected of substance abuse or have a history of it. This approach aims to identify infants with drug exposure and putative families with substance abuse disorders.
In some states, women can be charged criminally if their newborns test positive for drugs, while other states consider it child abuse, leading to the involvement of Child Protective Services. Tennessee is the only state with a statute explicitly criminalizing drug use during pregnancy. Alabama and South Carolina have similar interpretations, prosecuting drug-using pregnant women and new mothers under child endangerment laws.
While universal drug testing of newborns and mothers is not mandated by federal law, some states have legislation to protect infants. Only four states (North Dakota, Minnesota, Iowa, and Kentucky) require hospitals to test both mothers and infants if medical professionals suspect drug use or drug-related birth complications. In fifteen states, healthcare workers must report suspected drug abuse during pregnancy to the authorities.
The lack of standardized testing criteria and varying state laws contribute to inconsistent newborn drug testing practices across the country. The University of Utah Health's research highlights the controversy surrounding this issue, with efforts to understand the extent of drug deposition in newborns and its potential impact on breastfeeding.
Henderson, Nevada: Hospital Performance Review
You may want to see also
Explore related products

Mothers are advised to be truthful about their drug use to receive better care during pregnancy
Drug testing of newborns and their mothers is a controversial topic that is subject to extensive research and varying state laws. While there is no federal mandate requiring hospitals to test pregnant women or their newborns for drug exposure, individual states and medical institutions may have their own policies and protocols in place. In the context of Utah, here are some reasons why mothers are advised to be truthful about their drug use to receive better care during pregnancy:
Identifying Substance Abuse Disorders:
Being honest about drug use allows healthcare providers to identify mothers struggling with substance abuse disorders. This early identification is crucial for providing appropriate treatment and support to both the mother and the newborn, potentially reducing the harmful effects of drug exposure on the baby's development.
Personalised Care and Treatment:
When mothers disclose their drug use, healthcare professionals can tailor their care plans accordingly. This may include adjusting the approach to pregnancy care, offering specialised treatment for substance abuse, and providing guidance on breastfeeding to prevent further exposure through breast milk.
Legal Consequences and Child Custody:
In some states, drug use during pregnancy is considered a form of child abuse and can result in legal consequences, including criminal charges or involvement of Child Protective Services. Being truthful about drug use can help mothers understand the potential legal implications and make informed decisions to protect their rights and the best interests of their children.
Improving Data and Research:
Honest reporting of drug use contributes to more accurate data and research on the prevalence of substance use during pregnancy. This data is essential for developing effective prevention strategies, treatment programs, and support services for mothers and infants affected by substance use disorders.
Enhancing Newborn Care Protocols:
By disclosing drug use, mothers can help healthcare facilities establish unbiased guidelines and protocols for newborn care. This includes implementing standardised testing criteria, such as meconium and umbilical cord tissue testing, to identify infants who may have been exposed to drugs and require additional medical attention or withdrawal treatment.
While it may be challenging for mothers to admit their drug use, doing so can facilitate a more supportive and effective approach to pregnancy care, potentially reducing the harmful impacts on both mother and child. It is important to note that the specific laws and consequences related to drug use during pregnancy vary from state to state, and seeking legal advice is recommended in such cases.
Physician Employment: How Hospitals Hire Doctors
You may want to see also
Explore related products

Drug withdrawal symptoms in newborns include irritability, shrieks, seizures, and increased heart rate
In the United States, there is no federal law requiring hospitals to drug test newborns. However, due to the recent increase in opioid use and the resulting rise in babies born addicted, more states are adopting drug testing for newborns. Currently, only four states (North Dakota, Minnesota, Iowa, and Kentucky) mandate hospitals to test both mothers and newborns if drug use is suspected. Tennessee is the only state that explicitly criminalizes drug use during pregnancy.
When babies are exposed to drugs in the womb, they can experience drug withdrawal after birth, known as Neonatal Abstinence Syndrome (NAS). Opioids, including heroin, prescribed medicines like codeine and oxycodone, and methadone, are the most common drugs associated with NAS. Other substances such as amphetamines, cocaine, marijuana, and alcohol can also lead to NAS and cause specific issues in newborns.
Drug withdrawal symptoms in newborns vary but often include irritability, difficulty being comforted, increased activity, and poor feeding. More severe symptoms such as seizures, dehydration, vomiting, and diarrhea may also occur and require medical treatment. These symptoms can last for up to four to six months in some cases.
To diagnose and grade the severity of withdrawal, healthcare providers use a neonatal abstinence scoring system. This system assigns points to specific signs and symptoms to guide treatment planning. Treatment for newborns experiencing drug withdrawal may include swaddling, increased calorie formulas, IV fluids, and medications to alleviate severe symptoms and withdrawal discomfort.
Preparing Hospitals for Earthquakes: Strategies and Protocols
You may want to see also
Explore related products

Hospitals take a risk-based approach to testing infants, considering maternal history and social risk factors
There is no federal law that mandates hospitals to test pregnant women or their newborns for drug use. However, hospitals typically take a risk-based approach to testing infants, where medical staff will only drug test babies of mothers who are suspected of substance abuse or have a history of substance abuse. This approach considers maternal history and social risk factors to determine whether testing is necessary.
The risk-based approach uses hospital-defined criteria such as maternal history or signs of drug use, social risk factors, limited or absent prenatal care, and symptoms of withdrawal. For example, in Utah, Dr. McMillin mentions that they receive thousands of specimens a month for umbilical cord tissue and meconium testing to detect drug exposure in newborns. This testing helps counsel mothers on whether they should breastfeed, as psychoactive compounds in drugs like marijuana can concentrate in breast milk and expose the baby to dangerous amounts.
In addition to Utah, other states have also implemented laws and policies to address drug use during pregnancy and protect infants from exposure. Tennessee is the only state with a specific statute criminalizing drug use while pregnant. Alabama and South Carolina have interpreted child endangerment and chemical endangerment laws to allow the prosecution of pregnant women and new mothers who use drugs.
While some states have taken a more punitive approach, others focus on reporting and treatment. Fifteen states require healthcare workers to report suspected drug use during pregnancy to authorities. In three states (Minnesota, South Dakota, and Wisconsin), women who use drugs during pregnancy can be involuntarily committed to a treatment program. However, most states do not have laws requiring hospitals to test infants and new mothers for controlled substances, leaving it to hospital protocols and medical professionals' discretion.
The lack of standardized testing requirements and varying state laws have led to concerns about exposed infants slipping through the cracks. Child advocacy groups are advocating for universal drug testing of newborns and mothers upon delivery to ensure early identification and intervention. However, critics argue that universal testing is impractical and not cost-effective for healthcare institutions. Instead, they recommend establishing unbiased guidelines at each facility providing newborn care to identify those at risk and in need of testing.
Warren's Stance on Private Healthcare: Pros and Cons
You may want to see also
Explore related products

In some states, women can be charged with child abuse or criminally indicted for drug use during pregnancy
In the United States, there is no standardized federal legislation that mandates hospitals to drug test pregnant women or their newborns. However, some states have their own legislation regarding this issue. The law on drug testing newborns varies from state to state, and more states are adopting drug testing for newborns due to the recent increase in opioid use and the resulting rise in babies born addicted.
The punitive approach taken by some states has been criticized for exacerbating societal risk factors, worsening racial health disparities, and leading to negative outcomes for parents and children. It also acts as a deterrent for pregnant women seeking help for drug addiction, with the fear of losing custody of their children being a significant factor. Experts, including maternal/fetal specialists and federal health officials, are calling for changes to the laws, advocating for the removal of criminalization of pregnant women who use drugs. They argue that substance use disorder does not reflect a person's ability to parent and that treatment, not criminalization, is the appropriate approach.
The lack of standardized drug testing requirements in hospitals makes it challenging to determine the exact number of babies born with Neonatal Abstinence Syndrome (NAS). However, reports by the National Institute on Drug Abuse and the CDC state that 32,000 babies were born with NAS in 2014, a 400% increase from 2004. Hospitals typically take a risk-based approach to testing infants, drug testing babies of mothers with suspected or known histories of substance abuse. Some child advocacy groups are pushing for universal drug testing of newborns and mothers upon delivery to address this issue.
Food Poisoning: Hospital Treatment and Care
You may want to see also
Frequently asked questions
There is no federal law that requires hospitals to drug test newborns. The decision to test is typically made by doctors and hospitals, and they usually take a risk-based approach. Only four states (North Dakota, Minnesota, Iowa, and Kentucky) mandate hospitals to test both mothers and newborns if drug use is suspected.
Hospitals take a risk-based approach to testing infants. They consider maternal history of substance use disorder, signs of drug use, social risk factors, limited or absent prenatal care, and symptoms of withdrawal.
If a newborn tests positive for drugs, the consequences can be severe. The child may be removed from maternal custody by the state or an agency like Child Protective Services. In some states, women can be charged criminally, while other states consider it child abuse.

![Prime Screen [5 Pack] 6 Panel Urine Drug Test Kit (THC-Marijuana, BZO-Benzos, MET-Meth, OPI, AMP, COC), WDOA-264](https://m.media-amazon.com/images/I/71hU5zzuEaL._AC_UL320_.jpg)



![Easy@Home 5 Panel Urine Drug Test Kit [5 Pack] - THC/Marijuana, Cocaine, OPI/Opiates, AMP, BZO All Drugs Testing Strips in One Kit - at Home Use Screening Test with Results in 5 Mins #EDOAP-754](https://m.media-amazon.com/images/I/81pqr85M3-L._AC_UL320_.jpg)
![[5 pack] Prime Screen 14 Panel Urine Drug Test Cup - Instant Testing Marijuana (THC),OPI,AMP, BAR, BUP, BZO, COC, mAMP, MDMA, MTD, OXY, PCP, PPX, TCA](https://m.media-amazon.com/images/I/71cI114sLUL._AC_UL320_.jpg)
![Prime Screen 14 Panel Urine Drug Test Cup Instant Testing Marijuana (THC),OPI,AMP, BAR, BUP, BZO, COC, mAMP, MDMA, MTD, OXY, PCP, PPX, TCA [1 Pack]](https://m.media-amazon.com/images/I/7176xYFYqTL._AC_UL320_.jpg)


![Prime Screen 7 Panel Oral Saliva Drug Test Kit [5 Pack], Employment and Insurance Testing (AMP, COC, MET, OPI, OXY, PCP, THC) - ODOA-376](https://m.media-amazon.com/images/I/71HZu04wGYL._AC_UL320_.jpg)

![Prime Screen-12 Panel Multi Drug Urine Test Compact Cup (AMP,BAR,BUP,BZO,COC,mAMP/MET,MDMA,MOP/OPI,MTD,OXY,PCP,THC) C-Cup-[2 Pack]- CDOA-6125](https://m.media-amazon.com/images/I/81wHyqSLmsL._AC_UL320_.jpg)




![Prime Screen [5 Pack] 10 Panel Urine Drug Test Kit - Testing Instantly for THC (Marijuana), BZO (Benzos), MET (Meth), PCP (Phencyclidine), MTD, AMP, BAR, COC, OPI, MDMA - WDOA-3104](https://m.media-amazon.com/images/I/71MI2Y3yIRL._AC_UL320_.jpg)

![[5 Pack] Prime Screen 12 Panel Urine Test (AMP,BAR,BZO,COC,mAMP,MDMA,MOP/OPI 300,MTD,OXY,PCP,TCA,THC) - WDOA-7125](https://m.media-amazon.com/images/I/71Hy719lOfL._AC_UL320_.jpg)
![Prime Screen Multi-Drug Urine Test Cup 16 Panel Kit (AMP,BAR,BUP,BZO,COC,mAMP,MDMA,MOP/OPI,MTD,OXY,PCP,THC, ETG, FTY, TRA, K2) -[1 Pack]-CDOA-9165EFTK](https://m.media-amazon.com/images/I/718HvC-tp-L._AC_UL320_.jpg)

![Prime Screen [5 Pack] 12 Panel Urine Drug Test Kit (AMP, BAR, BUP, Benzos BZO, COC, mAMP, MDMA, MOP, MTD, OXY, PCP, Marijuana THC) - WDOA-6125](https://m.media-amazon.com/images/I/51jbz+-PFBL._AC_UL320_.jpg)

![Prime Screen [5 Pack] 5 Panel Urine Drug Test Kit - Testing Instantly for 5 Different Drugs AMP, COC, MET (Meth), OPI, THC (Marijuana) - WDOA-254](https://m.media-amazon.com/images/I/71FsDMfvdFL._AC_UL320_.jpg)







![[5 Pack] EZCHECK® 6-Panel Drug Test - at-Home Rapid Urine Screening Kit for 6 Most Used Drugs: (THC-Marijuana, BZO-Benzos, MET-Meth, OPI/MOP-Opiates, AMP-Amphetamine, COC)](https://m.media-amazon.com/images/I/71c1jjFYkLL._AC_UL320_.jpg)
![Easy@Home 5 Panel Urine Drug Test Kit [25 Pack] - THC/Marijuana, Cocaine, OPI, AMP, BZO All Drugs Testing Strips in One Kit - Home Use Drug Detox Tests with Results in 5 Mins #EDOAP-754](https://m.media-amazon.com/images/I/7133BQGIxiL._AC_UL320_.jpg)

![[5 Pack] Prime Screen Multi Drug Urine Test Cup -6 Panel (BZO,COC,mAMP,OPI, OXY,THC) C-CUP-TDOA-564](https://m.media-amazon.com/images/I/71ZZPH0MbUL._AC_UL320_.jpg)



![Safe Life[5 Pack] Fentanyl Single Panel Urine Test,Rapid Test Result in 5 Mins, Synthetic OPI Detecting Drug Testing Card, Cut-Off 20 ng/ml, Highly Sensitive Drug Test kit (5)](https://m.media-amazon.com/images/I/71tpHM6TcXL._AC_UL320_.jpg)

![[1 Test Cup] 14-Panel EZCHECK® Multi-Drug Urine Test Cup – at-Home Instant Testing for 14 Substances - Fast Result in 5 mins - FSA/HSA Eligible](https://m.media-amazon.com/images/I/71Geu5JRvZL._AC_UL320_.jpg)
![U Catch[5 Pack] 12 Panel Drug Test Kit: Multi Drug Urine Test Cup with Temperature Strip Rapid Detection at Home Screening Test Kit-No Leaking Large Size Detection Cup](https://m.media-amazon.com/images/I/61n9kHs-bAL._AC_UL320_.jpg)